<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 13.4: Glycemic Control: Insulin Sensitivity and Metabolic Syndrome</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - TEAL/GREEN theme for Endocrine/Metabolic */
        .module-header {
            background: linear-gradient(135deg, #0d9488 0%, #14b8a6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #0d9488;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #0d9488;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #0d9488;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f0fdfa;
            border: 2px solid #14b8a6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #0d9488;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #0d9488;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #333;
            margin: 30px 0 15px 0;
            font-weight: 600;
        }

        /* Content Styles */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        .stat-highlight {
            color: #0d9488;
            font-weight: 700;
        }

        /* Tables */
        .data-table-container {
            overflow-x: auto;
            margin: 35px 0;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        .data-table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        .data-table th {
            background: #f9fafb;
            padding: 15px;
            border-bottom: 2px solid #e5e7eb;
            color: #374151;
            font-weight: 600;
        }

        .data-table td {
            padding: 15px;
            border-bottom: 1px solid #f3f4f6;
            vertical-align: top;
        }

        .data-table tr:last-child td {
            border-bottom: none;
        }

        /* Case Study */
        .case-study {
            background: #f8fafc;
            border-radius: 16px;
            margin: 40px 0;
            overflow: hidden;
            border: 1px solid #e2e8f0;
        }

        .case-study-header {
            background: #0d9488;
            padding: 20px 30px;
            color: white;
        }

        .case-study-content {
            padding: 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 15px;
            margin-bottom: 20px;
            padding: 15px;
            background: white;
            border-radius: 10px;
            border: 1px solid #edf2f7;
        }

        .patient-avatar {
            width: 50px;
            height: 50px;
            background: #14b8a6;
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            color: white;
            font-weight: bold;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #0d9488 0%, #14b8a6 100%);
            padding: 35px;
            border-radius: 16px;
            margin: 35px 0;
            color: white;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(180px, 1fr));
            gap: 25px;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 36px;
            font-weight: 700;
            display: block;
            margin-bottom: 5px;
        }

        .stat-label {
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 1px;
            opacity: 0.9;
        }

        /* Check Your Understanding */
        .check-understanding {
            background: #fffaf0;
            border: 2px solid #ed8936;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            margin-bottom: 25px;
        }

        .reveal-btn {
            background: #ed8936;
            color: white;
            border: none;
            padding: 8px 18px;
            border-radius: 6px;
            cursor: pointer;
            font-size: 14px;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #fff;
            border-radius: 8px;
            border-left: 4px solid #ed8936;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f3f4f6;
            padding: 30px;
            border-radius: 12px;
            margin: 40px 0;
        }

        .references-box {
            background: #ffffff;
            border-top: 1px solid #eee;
            padding: 30px 0;
            font-size: 14px;
            color: #666;
        }

        .lesson-footer {
            text-align: center;
            padding: 40px 0;
            border-top: 1px solid #eee;
        }

        /* R.O.O.T.S. Method Callout */
        .roots-callout {
            border-left: 5px solid #B8860B;
            background: #fdfaf3;
            padding: 25px;
            margin: 30px 0;
            border-radius: 0 12px 12px 0;
        }

        .roots-callout h4 {
            margin-top: 0;
            color: #8B6914;
            font-size: 16px;
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        @media (max-width: 768px) {
            .toc-list { grid-template-columns: 1fr; }
            .lesson-container { padding: 20px 15px; }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 13: The Endocrine System & Metabolic Balance</p>
            <h1 class="lesson-title">Lesson 13.4: Glycemic Control: Insulin Sensitivity and Metabolic Syndrome</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Lesson 4 of 6</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#pathophysiology"><span class="section-num">1</span>Insulin Resistance Mechanisms</a></li>
                <li><a href="#metabolic-syndrome"><span class="section-num">2</span>The MetS Landscape</a></li>
                <li><a href="#berberine"><span class="section-num">3</span>Berberine: The Metformin Rival</a></li>
                <li><a href="#synergy"><span class="section-num">4</span>Synergistic Formulations</a></li>
                <li><a href="#traditional"><span class="section-num">5</span>The Bitter Reflex & GLP-1</a></li>
                <li><a href="#clinical"><span class="section-num">6</span>Clinical Application</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Analyze the molecular pathophysiology of <span class="highlight">GLUT-4 translocation</span> and its role in insulin resistance.</li>
                <li>Compare the clinical efficacy and mechanisms of Berberine versus Metformin based on recent meta-analyses.</li>
                <li>Apply the 'O' (Organize) principle to create synergistic formulas using Bitter Melon and Cassia Cinnamon.</li>
                <li>Integrate 'T' (Traditional Wisdom) regarding bitter tonics to enhance postprandial glucose responses via T2R receptors.</li>
                <li>Identify key diagnostic markers for Metabolic Syndrome and the impact of botanicals on HbA1c levels.</li>
            </ul>
        </div>

        <p>In our previous lessons, we explored the HPA axis and Thyroid vitality, establishing how stress and basal metabolism dictate systemic energy. However, the "currency" of this energyâ€”blood glucoseâ€”must be managed with exquisite precision. When glycemic control falters, the entire endocrine landscape shifts toward a state of <span class="highlight">metabolic inflexibility</span>, leading to the cluster of pathologies known as Metabolic Syndrome.</p>

        <h2 id="pathophysiology">1. The Pathophysiology of Insulin Resistance</h2>
        <p>Insulin resistance is not merely a "lack of response" to insulin; it is a complex intracellular signaling failure. At the heart of this failure is the <span class="highlight">GLUT-4 (Glucose Transporter Type 4)</span> protein. Under normal conditions, insulin binds to its receptor, triggering a cascade that moves GLUT-4 from storage vesicles to the cell membrane, allowing glucose entry.</p>

        <p>In a resistant state, chronic low-grade inflammationâ€”driven by <span class="highlight">TNF-alpha and Interleukin-6 (IL-6)</span>â€”interferes with the phosphorylation of Insulin Receptor Substrate 1 (IRS-1). This molecular "jamming" prevents GLUT-4 from translocating. Consequently, glucose remains in the bloodstream (hyperglycemia), and the pancreas compensates by secreting even more insulin (hyperinsulinemia).</p>

        <div class="roots-callout">
            <h4>R.O.O.T.S. Method: Research (R)</h4>
            <p>Modern research identifies <span class="highlight">mitochondrial dysfunction</span> as a primary driver of insulin resistance. When mitochondria are overwhelmed by caloric excess, they produce Reactive Oxygen Species (ROS) that further damage insulin signaling pathways. As practitioners, our goal is to restore mitochondrial efficiency alongside glycemic control.</p>
        </div>

        <h2 id="metabolic-syndrome">2. Metabolic Syndrome: The "Deadly Quartet"</h2>
        <p>Metabolic Syndrome (MetS) is a clinical diagnosis characterized by a cluster of at least three of the following five conditions. This syndrome increases the risk of Type 2 Diabetes (T2DM) by fivefold and cardiovascular disease by twofold.</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <span class="stat-number">34.7%</span>
                    <span class="stat-label">US Adults with MetS</span>
                </div>
                <div class="stat-item">
                    <span class="stat-number">0.6-1.2%</span>
                    <span class="stat-label">HbA1c reduction with Berberine</span>
                </div>
                <div class="stat-item">
                    <span class="stat-number">5X</span>
                    <span class="stat-label">T2DM Risk Increase</span>
                </div>
            </div>
        </div>

        <div class="data-table-container">
            <table class="data-table">
                <thead>
                    <tr>
                        <th>Marker</th>
                        <th>MetS Threshold</th>
                        <th>Pathophysiological Significance</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Fasting Blood Glucose</strong></td>
                        <td>&ge; 100 mg/dL</td>
                        <td>Indicates hepatic insulin resistance and impaired gluconeogenesis.</td>
                    </tr>
                    <tr>
                        <td><strong>Waist Circumference</strong></td>
                        <td>&gt; 40in (M) / 35in (F)</td>
                        <td>Visceral fat acts as an endocrine organ secreting pro-inflammatory adipokines.</td>
                    </tr>
                    <tr>
                        <td><strong>Triglycerides</strong></td>
                        <td>&ge; 150 mg/dL</td>
                        <td>Reflects high VLDL production and liver fat accumulation.</td>
                    </tr>
                    <tr>
                        <td><strong>HDL Cholesterol</strong></td>
                        <td>&lt; 40 (M) / 50 (F)</td>
                        <td>Loss of reverse cholesterol transport; increased atherogenic risk.</td>
                    </tr>
                    <tr>
                        <td><strong>Blood Pressure</strong></td>
                        <td>&ge; 130/85 mmHg</td>
                        <td>Insulin resistance impairs nitric oxide production, causing vasoconstriction.</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="berberine">3. Berberine: The Clinical Metformin Rival</h2>
        <p>Berberine, an isoquinoline alkaloid found in <i>Coptis chinensis</i> and <i>Hydrastis canadensis</i>, has become the gold standard in botanical glycemic management. Its mechanism is strikingly similar to Metformin: the activation of <span class="highlight">AMP-activated protein kinase (AMPK)</span>.</p>

        <p>AMPK acts as the "metabolic master switch." When activated, it promotes GLUT-4 translocation independently of insulin, increases fatty acid oxidation in the liver, and inhibits gluconeogenesis. A 2021 meta-analysis of 28 randomized controlled trials (n=2,314) concluded that Berberine combined with lifestyle intervention was significantly more effective than lifestyle intervention alone in reducing FBG and HbA1c.</p>

        <div class="case-study">
            <div class="case-study-header">
                <strong>CASE STUDY 1: Reversing Pre-Diabetes</strong>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">S</div>
                    <div>
                        <strong>Sarah (45), High-Stress Executive</strong><br>
                        Symptoms: Weight gain (central), fatigue after meals, FBG 112 mg/dL, HbA1c 5.9%.
                    </div>
                </div>
                <p><strong>Intervention:</strong> Sarah was placed on a protocol of Berberine (500mg, 3x daily before meals) and <i>Cinnamomum cassia</i> (2g daily). We integrated the 'T' principle of "Bitter Before Meals" using a tincture of <i>Gentiana lutea</i>.</p>
                <p><strong>Outcomes:</strong> After 12 weeks, Sarah's FBG dropped to 94 mg/dL and HbA1c reached 5.4%. She reported a 60% reduction in "brain fog" and lost 8 lbs of visceral weight. Her results demonstrated the synergy between AMPK activation and bitter-mediated GLP-1 release.</p>
            </div>
        </div>

        <h2 id="synergy">4. Organizing Formulas ('O'): Synergistic Blends</h2>
        <p>In the R.O.O.T.S. Method, we organize formulas using the Tripartite structure (King, Minister, Messenger). For metabolic balance, we look for herbs that address different nodes of the glycemic pathway.</p>

        <h3>The "Glycemic Triad" Formula</h3>
        <ul>
            <li><strong>The King (Action): <i>Momordica charantia</i> (Bitter Melon).</strong> Contains polypeptide-p, an insulin-mimetic protein that lowers glucose levels by increasing glucose uptake in muscle and liver.</li>
            <li><strong>The Minister (Support): <i>Cinnamomum cassia</i> (Cassia Cinnamon).</strong> A potent insulin sensitizer. It contains methylhydroxychalcone polymers (MHCP) that mimic insulin and act synergistically with endogenous insulin.</li>
            <li><strong>The Messenger (Delivery/Direction): <i>Zingiber officinale</i> (Ginger).</strong> Enhances peripheral circulation to ensure botanical constituents reach receptor sites and improves digestive thermogenesis.</li>
        </ul>

        <p>Research indicates that <span class="stat-highlight">Cinnamon can reduce FBG by 18-29%</span> in T2DM patients. When combined with Bitter Melon, which addresses hepatic glucose output, the effect is multifacetedâ€”addressing both the source (liver) and the destination (muscle) of glucose.</p>

        <h2 id="traditional">5. Traditional Wisdom ('T') & The Bitter Reflex</h2>
        <p>Traditional systems (Ayurveda and TCM) have long utilized "bitters" for metabolic disorders. Modern science now validates this via the discovery of <span class="highlight">T2R (Bitter Taste Receptors)</span> located not only on the tongue but throughout the gastrointestinal tract and pancreas.</p>

        <p>When bitter compounds (like those in <i>Momordica</i> or <i>Gentiana</i>) bind to T2R receptors in the gut, they stimulate the release of <span class="highlight">Glucagon-like peptide-1 (GLP-1)</span>. This is the same hormone targeted by modern blockbuster weight-loss drugs. GLP-1 slows gastric emptying, increases insulin secretion, and induces satiety. By using the 'T' of bitter tonics, we leverage an ancient physiological reflex to manage a modern metabolic crisis.</p>

        <div class="case-study">
            <div class="case-study-header">
                <strong>CASE STUDY 2: Metabolic Syndrome & Dyslipidemia</strong>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">M</div>
                    <div>
                        <strong>Marcus (52), Sedentary Lifestyle</strong><br>
                        Symptoms: BP 145/92, Triglycerides 210, Waist 42", FBG 108.
                    </div>
                </div>
                <p><strong>Intervention:</strong> Focused on the 'O' of formulation. Used a "Metabolic Tonic" featuring <i>Berberis aristata</i> (Tree Turmeric), <i>Silybum marianum</i> (Milk Thistle) to address hepatic fat, and <i>Gymnema sylvestre</i> to reduce sugar cravings.</p>
                <p><strong>Outcomes:</strong> 16-week follow-up showed Triglycerides dropped to 145 (within normal range) and systolic BP decreased by 12 mmHg. Marcus noted that <i>Gymnema</i> made sweets taste "unappealing," aiding his dietary 'S' (Sustainable) changes.</p>
            </div>
        </div>

        <h2 id="clinical">6. Clinical Application and Safety</h2>
        <p>While botanicals are powerful, the practitioner must navigate the "Safety" (S) pillar of the R.O.O.T.S. framework, particularly regarding Herb-Drug Interactions (HDI).</p>

        <div class="roots-callout">
            <h4>Practitioner Safety Note</h4>
            <p>Berberine is a potent inhibitor of <span class="highlight">CYP3A4</span> and CYP2D6 enzymes. It can significantly increase the blood levels of drugs like Cyclosporine, Warfarin, and certain statins. Always cross-reference the client's medication list before initiating high-dose Berberine therapy.</p>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <div class="question-item">
                <p class="question-text">1. What is the primary mechanism by which Berberine mimics the effects of Metformin?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Berberine activates AMPK (AMP-activated protein kinase), which promotes insulin-independent GLUT-4 translocation and inhibits hepatic gluconeogenesis.</div>
            </div>
            <div class="question-item">
                <p class="question-text">2. How do bitter botanicals influence GLP-1 levels?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Bitters bind to T2R receptors in the gut, triggering the secretion of GLP-1, which enhances insulin sensitivity, slows gastric emptying, and promotes satiety.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>Insulin Resistance</strong> is a signaling failure involving impaired GLUT-4 translocation driven by chronic inflammation.</li>
                <li><strong>Berberine</strong> is clinically comparable to Metformin, showing significant reductions in HbA1c (0.6-1.2%) via AMPK activation.</li>
                <li><strong>Synergistic Formulation</strong> ('O') should combine insulin mimetics (Bitter Melon) with sensitizers (Cinnamon).</li>
                <li><strong>Traditional Bitters</strong> ('T') leverage the T2R-GLP-1 axis to improve postprandial glycemic response.</li>
                <li><strong>Safety First:</strong> Always monitor for CYP3A4 interactions when using high-dose Berberine.</li>
            </ul>
        </div>

        <div class="references-box">
            <p><strong>References & Further Reading:</strong></p>
            <ul>
                <li>Ye et al. (2021). "Efficacy and Safety of Berberine in Treatment of Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis." <i>Evidence-Based Complementary and Alternative Medicine.</i></li>
                <li>Wang et al. (2023). "GLUT4 Translocation and Insulin Resistance: Molecular Mechanisms and Therapeutic Targets." <i>Frontiers in Endocrinology.</i></li>
                <li>Leach et al. (2020). "Cinnamon for Diabetes Mellitus: A Cochrane Systematic Review." <i>Cochrane Database of Systematic Reviews.</i></li>
                <li>Tiwari et al. (2022). "Antidiabetic potential of Momordica charantia: A review of its biological and pharmacological activities." <i>Journal of Ethnopharmacology.</i></li>
                <li>Kim et al. (2019). "The Role of Bitter Taste Receptors (T2Rs) in Glucagon-like Peptide-1 Secretion." <i>Molecular Metabolism.</i></li>
                <li>Al-Ishaq et al. (2019). "Flavonoids and Their Anti-Diabetic Effects: Cellular Mechanisms and Effects on Glycemia." <i>Nutrients.</i></li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Certified Herbalism Practitioner Program</p>
            <p class="copyright">&copy; 2024 AccrediPro Academy. All Rights Reserved. Confidential & Proprietary.</p>
        </footer>
    </div>
</body>

</html>